Prevention or delay of onset of psychosis in an 'ultra high risk' group: A comparison of risperidone and placebo in combination with intensive psychological treatment
Latest Information Update: 10 Jul 2019
At a glance
- Drugs Risperidone (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Therapeutic Use
- Acronyms RIS-AUS-9
- Sponsors Janssen-Cilag
- 10 Jul 2019 The actual last participant enrolled date is 6/15/2005.
- 29 Jun 2016 New trial record